The Top 8 Monster Funds stocks to own in March 2019

Kinetics Market Opportunities [KMKNX] is traded in USA and was established 19th of April 2024. Kinetics Market is listed under Kinetics category by Fama And French industry classification. The fund is listed under Mid-Cap Growth category and is part of Kinetics family. The entity is thematically classified as Monster Funds. This fund now has accumulated 116.21 M in assets with no minimum investment requirementsKinetics Market Oppo is currently producing year-to-date (YTD) return of 15.96% with the current yeild of 0.01%, while the total return for the last 3 years was 2.17%. At this time, the fund appears to be undervalued. Kinetics Market Oppo secures a last-minute Real Value of $52.06 per share. The latest price of the fund is $48.52. We determine the value of Kinetics Market Oppo from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.

Franklin Gold Precious [FGADX] is traded in USA and was established 19th of April 2024. Franklin Gold is listed under Franklin Templeton Investments category by Fama And French industry classification. The fund is listed under Equity Precious Metals category and is part of Franklin Templeton Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 729.8 M in assets under management (AUM) with minimum initial investment of 100 K. Franklin Gold Precious is currently producing year-to-date (YTD) return of 10.07% with the current yeild of 0.03%, while the total return for the last 3 years was -5.71%.

Fidelity Advisor Biotechnology [FBTTX] is traded in USA and was established 19th of April 2024. Fidelity Advisor is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 2.85 B in assets under management (AUM) with no minimum investment requirementsFidelity Advisor Bio is currently producing year-to-date (YTD) return of 3.72% with the current yeild of 0.01%, while the total return for the last 3 years was 2.12%. At this time, the entity appears to be fairly valued. Fidelity Advisor Bio shows a prevailing Real Value of $26.06 per share. The current price of the fund is $25.67. We determine the value of Fidelity Advisor Bio from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.

Fidelity Advisor Biotechnology [FBTAX] is traded in USA and was established 19th of April 2024. Fidelity Advisor is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 2.85 B in assets under management (AUM) with no minimum investment requirementsFidelity Advisor Bio is currently producing year-to-date (YTD) return of 3.8% with the current yeild of 0.01%, while the total return for the last 3 years was 2.41%.

Matthews Pacific Tiger [MIPTX] is traded in USA and was established 19th of April 2024. Matthews Pacific is listed under Matthews Asia Funds category by Fama And French industry classification. The fund is listed under Pacific/Asia ex-Japan Stk category and is part of Matthews Asia Funds family. The entity is thematically classified as Monster Funds. This fund now has accumulated 3.79 B in assets with no minimum investment requirementsMatthews Pacific Tiger is currently producing year-to-date (YTD) return of 0.54% with the current yeild of 0.03%, while the total return for the last 3 years was -11.75%. At this time, the fund appears to be fairly valued. Matthews Pacific Tiger secures a last-minute Real Value of $17.92 per share. The latest price of the fund is $17.86. We determine the value of Matthews Pacific Tiger from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.

Fidelity Real Estate [FRESX] is traded in USA and was established 19th of April 2024. Fidelity Real is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Real Estate category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 2.83 B in assets under management (AUM) with no minimum investment requirementsFidelity Real Estate is currently producing year-to-date (YTD) return of 10.87% with the current yeild of 0.02%, while the total return for the last 3 years was 0.16%.

Fidelity Real Estate [FSRNX] is traded in USA and was established 19th of April 2024. Fidelity Real is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Real Estate category and is part of Fidelity Investments family. The entity is thematically classified as Baby Boomer Prospects. This fund currently has accumulated 2.43 B in assets under management (AUM) with no minimum investment requirementsFidelity Real Estate is currently producing year-to-date (YTD) return of 11.94% with the current yeild of 0.03%, while the total return for the last 3 years was -1.02%. At this time, the entity appears to be fairly valued. Fidelity Real Estate shows a prevailing Real Value of $14.37 per share. The current price of the fund is $14.19. We determine the value of Fidelity Real Estate from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.

Cohen And Steers [CSRIX] is traded in USA and was established 19th of April 2024. Cohen is listed under Cohen & Steers category by Fama And French industry classification. The fund is listed under Real Estate category and is part of Cohen & Steers family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 5.74 B in assets under management (AUM) with minimum initial investment of 1000 K. Cohen And Steers is currently producing year-to-date (YTD) return of 0.32% with the current yeild of 0.03%, while the total return for the last 3 years was 0.66%.